Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Total Non-Current Liabilities: 2010-2025

Historic Total Non-Current Liabilities for Lifecore Biomedical (LFCR) over the last 10 years, with May 2025 value amounting to $166.9 million.

  • Lifecore Biomedical's Total Non-Current Liabilities fell 4.43% to $166.9 million in Q2 2025 from the same period last year, while for May 2025 it was $166.9 million, marking a year-over-year decrease of 4.43%. This contributed to the annual value of $166.9 million for FY2025, which is 4.43% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Total Non-Current Liabilities of $166.9 million as of Q2 2025, which was up 0.33% from $166.4 million recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's Total Non-Current Liabilities peaked at $301.6 million during Q1 2021, and registered a low of $153.6 million during Q2 2023.
  • Its 3-year average for Total Non-Current Liabilities is $165.7 million, with a median of $165.1 million in 2024.
  • As far as peak fluctuations go, Lifecore Biomedical's Total Non-Current Liabilities crashed by 39.95% in 2022, and later grew by 18.43% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Total Non-Current Liabilities (Quarterly) stood at $264.0 million in 2021, then decreased by 22.47% to $204.6 million in 2022, then declined by 22.07% to $159.5 million in 2023, then rose by 8.06% to $172.3 million in 2024, then fell by 4.43% to $166.9 million in 2025.
  • Its Total Non-Current Liabilities stands at $166.9 million for Q2 2025, versus $166.4 million for Q1 2025 and $172.3 million for Q4 2024.